March 15, 2024 By Silvia Ruojin Ren, OD, MD, PhD Commitment to continuous learning is crucial given the dynamic nature of myopia...
sponsored content March 1, 2024 The evidence supporting the use of topical low-dose atropine in treating juvenile-onset myopia is so strong that...
March 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The prevalence of myopia has been increasing globally, and it is...
February 15, 2024 By Glenda Aleman, OD Transparency can establish trust when talking to patients and parents about off-label treatments. I don’t...
February 15, 2024 By Nida Sherwani, OD I’ve been afforded the opportunity to dedicate myself wholeheartedly to myopia management. With newfound autonomy,...
February 1, 2024 By Luke Seesink, BApplSci According to this study, there is significant variability in the quality and consistency of compounded...
January 18, 2024 NEW YORK — Eyenovia has regained the rights to MicroPine, an investigational eight microliter ophthalmic spray of atropine delivered by...
January 15, 2024 Review of Myopia Management interviewed Robert Clark, MD, to get the latest insights on treating myopes with low-dose atropine....
January 15, 2024 By Tobin Ansel, OD, MS, FAAO Implementing myopia management into practice is a process, and it starts with something...
January 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE According to the International Myopia Institute (IMI) white paper Defining and...
January 1, 2024 By Huy Tran, MD, PhD, and Thi D. Duong, BOptom While myopia control treatment has been successfully adopted worldwide,1...
January 1, 2024 By Thomas Naduvilath, Msc Biostatistics, PhD, Head of Biostatistics at BHVI With the emphasis of myopia control to reduce axial...
December 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Clinical trial results of topical atropine eye drops for childhood myopia...
December 1, 2023 By Vaughn Brinegar, OD Myopia management allows you to really get to know your patients and their personalities because...
sponsored content November 1, 2023 By Erin S. Tomiyama, OD, PhD, FAAO Most compounding pharmacies are small and do not have the...
November 1, 2023 By Melanie Frogozo, OD, FAAO While recently FDA-approved treatment options are available, it benefits patients and providers alike to...
October 27, 2023 SALT LAKE CITY — iVeena Delivery Systems‘ Dr. Sarah Molokhia, vice president of research and development, was awarded a...
October 16, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Logan and Bullimore, in their article “Optical Interventions for Myopia Control,”...
October 16, 2023 By Gina Wesley, OD, MS, FAAO As a clinician, and a myopia researcher, I feel it is my duty...
October 11, 2023 BRIDGEWATER, N.J. — Vyluma has released the results from the second stage of Phase III of its CHAMP (Childhood...
October 2, 2023 By Wes McCann, OD Initiating a dialogue with a myopic adult about the risks posed to their children requires...
September 15, 2023 By Grant Miller, OD My goal with myopia management is to provide an experience. I’ve created the Myopia Management...
SAN DIEGO — Sydnexis Inc., a clinical stage biopharmaceutical company focused on the treatment of progressive myopia in children and minimizing the...
sponsored content August 15, 2023 By Kristen Dalli, Managing Editor, Review of Myopia Management ‘Pediatric ophthalmologists are the tip of the spear....
August 15, 2023 By Nayiri Ajoian, OD The success of myopia management has a lot to do with the fact that my...
sponsored content August 15, 2023 Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence...
August 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Eye care professionals frequently prescribe topical low-dose atropine to slow myopic...